Inhalable Car-T Cell-Derived Exosomes As Paclitaxel Carriers for Treating Lung Cancer

Investigators engineered exosomes derived from T cells expressing the chimeric antigen receptor (CAR-Exos), which targeted mesothelin (MSLN)-expressing Lewis lung cancer through the anti-MSLN single-chain variable fragment of CAR-Exos.